Godefridus J. Peters
Arzt
Hat mitgewirkt an:
-
Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
-
Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models
-
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
-
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126